✦ LIBER ✦

P.1.a.009 CYP2D6 polymorphism in patients with Alzheimer's disease in treatment with cholinesterase inhibitors

✍ Scribed by M. Fontana; R. Squitti; C. Bonvicini; L. Benussi; L. Bocchio Chiavetto; M. Ventriglia

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

BCHEandCYP2D6genetic variation in Alzhei

✍ Caterina Chianella; Daniela Gragnaniello; Pierpaolo Maisano Delser; Maria France 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 281 KB

Defining optimal treatment with cholines

✍ Gary Small; Roger Bullock 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 811 KB

P2-360 Treatment of Alzheimer's disease

✍ Faltraco, Frank; Happich, Michael; Reisig, Veromika; Teipel, Stefan J.; Moeller, 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 158 KB

ADHERENCE TO CHOLINESTERASE INHIBITORS I

✍ Lucie Blais; Fatima-Zohra Kettani; Sylvie Perreault; Jean-Christophe Leroux; Amé 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Significance of syncope in patients with

✍ Bordier, P 📂 Article 📅 2003 🏛 Oxford University Press 🌐 English ⚖ 88 KB

P.3.13 Clinical impact of CYP2D6 polymor

✍ M.G. Scordo; E. Varsaldi; G. Miglio; M.L. Villa; A. Biolcati; M.-L. Dahl; G. Lom 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 116 KB